Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWetherspoon (J.D) Regulatory News (JDW)

Share Price Information for Wetherspoon (J.D) (JDW)

Share Price is delayed by 15 minutes
Get Live Data
649.00    19.00 (3.02%)
Bid:
646.00
Ask:
647.50
Spread: 1.50 (0.232%)
Market Cap: £684.08m
JDW Live PriceLast checked at - London Stock Exchange

Intraday Wetherspoon (J.D) Share Chart

Directorate Change

4 Nov 2022 15:19

RNS Number : 4239F
Wetherspoon (JD) PLC
04 November 2022
 

4 November 2022

J D WETHERSPOON PLC

 

Directorate Change

 

Further to the announcement of 4th May 2022, the Company confirms that Su Cacioppo retired from her role as Personnel and Legal Director on 7th October 2022.

 

Su Cacioppo will continue to provide part-time consultancy services to the company for an initial period of 12 months.

 

As set out in the 2022 Director's Remuneration Report, a discretionary bonus award under the Deferred Bonus Scheme was made to the Company's senior management, including executive directors.

 

This resulted in a post termination award of 25% of salary to Su Cacioppo on 4th November which totalled £89,595.25 subject to tax and NI deductions.

 

The award will be made in three equal annual tranches, commencing on the award date of 4th November. The tranches can be taken as a cash award or equivalent value in shares.

 

 

 

Enquiries:

Eddie Gershon Company Spokesman 07956 392234

 

Notes to editors

1. J D Wetherspoon owns and operates pubs throughout the UK. The company aims to provide customers with good-quality food and drink, served by well-trained and friendly staff, at reasonable prices. The pubs are individually designed, and the company aims to maintain them in excellent condition.

 

2. Visit our website: www.jdwetherspoon.com

 

3. This announcement has been prepared solely to provide additional information to the shareholders of J D Wetherspoon, to meet the requirements of the FCA's Disclosure and Transparency Rules. It should not be relied on by any other party, for any other purposes. Forward-looking statements have been made by the directors in good faith, using information available up until the date on which they approved this statement. Forward-looking statements should be regarded with caution, because of the inherent uncertainties in economic trends and business risks.

 

4. The current financial year comprises 52 trading weeks to 30 July 2023.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUPGRUGUPPGAC
Date   Source Headline
13th Oct 20254:06 pmRNSDirector/PDMR Shareholding
8th Oct 20252:51 pmRNSDirector/PDMR Shareholding
8th Oct 20252:35 pmRNSDirector/PDMR Shareholding
8th Oct 20252:18 pmRNSHolding(s) in Company
6th Oct 20254:21 pmRNSStatement re Press Comment
6th Oct 20253:35 pmRNSHolding(s) in Company
3rd Oct 20259:00 amRNSAnnual Financial Report
3rd Oct 20257:00 amRNSPreliminary Results
29th Sep 20252:21 pmRNSDirector/PDMR Shareholding
24th Sep 20259:59 amRNSHolding(s) in Company
9th Sep 202510:46 amRNS-RPubs Need Tax Equality, Not Tax Complexity
22nd Aug 20253:47 pmRNSDirector/PDMR Shareholding
5th Aug 20258:40 amRNSHolding(s) in Company
4th Aug 202510:11 amRNSTotal Voting Rights
28th Jul 202511:43 amRNSDirector/PDMR Shareholding
24th Jul 20251:47 pmRNSDirector/PDMR Shareholding
23rd Jul 20257:00 amRNSPre-close trading update
15th Jul 20253:01 pmRNSTotal Voting Rights
14th Jul 20257:00 amRNSTransaction in Own Shares
11th Jul 20257:00 amRNSTransaction in Own Shares
10th Jul 20257:00 amRNSTransaction in Own Shares
9th Jul 20257:00 amRNSTransaction in Own Shares
8th Jul 20254:12 pmRNSTotal Voting Rights
8th Jul 20257:00 amRNSTransaction in Own Shares
3rd Jul 20257:00 amRNSTransaction in Own Shares
2nd Jul 20257:00 amRNSTransaction in Own Shares
1st Jul 20252:51 pmRNSTotal Voting Rights
27th Jun 20251:48 pmRNSDirector/PDMR Shareholding
24th Jun 20252:53 pmRNSTotal Voting Rights
24th Jun 20257:00 amRNSTransaction in Own Shares
20th Jun 20257:00 amRNSTransaction in Own Shares
17th Jun 20254:09 pmRNSTotal Voting Rights
13th Jun 20257:00 amRNSTransaction in Own Shares
12th Jun 20258:23 amRNSHolding(s) in Company
11th Jun 20252:13 pmRNSTotal Voting Rights
11th Jun 20257:00 amRNSTransaction in Own Shares
10th Jun 20257:00 amRNSTransaction in Own Shares
9th Jun 20257:00 amRNSTransaction in Own Shares
6th Jun 20257:00 amRNSTransaction in Own Shares
3rd Jun 202510:50 amRNSHolding(s) in Company
2nd Jun 20257:00 amRNSTotal Voting Rights
29th May 202511:34 amRNSTotal Voting Rights
27th May 20253:16 pmRNSDirector/PDMR Shareholding
27th May 20253:07 pmRNSDirector/PDMR Shareholding
27th May 202511:38 amRNSDirector/PDMR Shareholding
27th May 20257:00 amRNSTransaction in Own Shares
20th May 20257:00 amRNSTransaction in Own Shares
8th May 20252:08 pmRNSStatement re Press Comment
8th May 202511:06 amRNSTotal Voting Rights
7th May 20257:00 amRNSTrading Update Announcement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.